No vitamin D threshold for calcium absorption: why does this matter? [1] [2] [3] Sue A Shapses
It has long been known that 1,25-dihydroxyvitamin D stimulates calcium absorption and that there is a correlation between serum 25-hydroxyvitamin D [25(OH)D] 4 and calcium absorption at low serum concentrations when transcellular processes are more important (1) . Calcium absorption has been used as one of several measures to determine vitamin D intake requirements or sufficiency (2) . Previously, it was suggested that there was a threshold for maximal calcium absorption at a serum 25(OH)D concentration of 80 nmol/L (32 ng/mL), with a steep increase starting from 28 nmol/L (3). The basis for this threshold was data from a study that used a single-isotope method that showed no difference in fractional calcium absorption (FCA) from 75 to 125 nmol/L (3). Other suggested threshold values (29, 50, and 85 nmol/L) for maximal calcium absorption were from studies that did not directly measure calcium absorption (3) . The need to clarify the calcium absorption threshold was pointed out by the Institute of Medicine committee to determine the vitamin D and calcium requirements in its 2011 report, because at the time there were no published randomized controlled trials (RCTs) to indicate whether a threshold even existed above 25(OH)D concentrations considered to be deficient (2) . Since that time, 3 RCTs have been published, including the study published in this issue of the Journal (4).
In the study by Aloia et al (4) , the FCA response to multiple doses of supplemental vitamin D 3 was measured for the first time by using the more precise dual-isotope method (4). This trial, which reported a baseline 25(OH)D concentration of 63 nmol/L, found no threshold for calcium absorption at the various doses of vitamin D supplementation. Specifically, after 8 wk, the researchers found increases of 3.9%, 5.0%, and 6.7% in FCA in response to 800, 2000, and 4000 IU vitamin D 3 /d, respectively, by using a 300-mg Ca load. The placebo group without any supplementation decreased FCA by 2.6%. There are at least 2 reasons why these findings are important. First, whereas some available evidence seemed to have suggested that there was no serum 25(OH)D threshold for FCA (5, 6) , only a dose-response study can definitively prove this. Second, the decrease in the placebo group is not surprising given that typical dietary vitamin D intake is low in this group of women (2, 5) who tend to take a small amount of supplements before entering a trial (2) . The decrease in FCA underscores the need for adequate vitamin D in maintaining calcium absorption.
Additional information is available from 2 other recent doubleblind controlled studies that used vitamin D 3 supplementation in postmenopausal women with adequate calcium intake (5, 7). In the Gallagher et al (7) study, multiple doses of vitamin D 3 were used from 400 to 4800 IU/d, and findings showed that there was a 6% increase in FCA by using the single-isotope method and a low calcium carrier load (100 mg). These findings are consistent with the Aloia et al study, which showed a 6.7% increase in FCA when women were supplemented with 4000 IU/d and given a 300-mg Ca load (4). In our laboratory (5), we used a similar dual stable-isotope method with a 300-mg carrier Ca load and a similar baseline serum 25(OH)D concentration in postmenopausal women. In this study, vitamin D 3 intake increased from 400 to 2500 IU/d, and there was a 3.7% increase in FCA. The slightly greater increase in FCA of 5% in the Aloia et al study using nearly identical methods may be explained by an absence of any vitamin D supplementation in the control group (4). In addition, an earlier study (6) Where does this leave us at the moment? There are 2 implications. The Dietary Reference Intake should not rely on calcium absorption as a measure of vitamin D sufficiency to determine adequate intake. It is important to consume the recommended intakes of vitamin D and calcium to avoid low net calcium absorption and to maintain bone health.
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